| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5283227
Max Phase: Preclinical
Molecular Formula: C12H11Cl2NO
Molecular Weight: 256.13
Associated Items:
Representations
Canonical SMILES: CC(C)c1ccc2c(Cl)cc(Cl)c(O)c2n1
Standard InChI: InChI=1S/C12H11Cl2NO/c1-6(2)10-4-3-7-8(13)5-9(14)12(16)11(7)15-10/h3-6,16H,1-2H3
Standard InChI Key: VCSWRSSQIKWMIU-UHFFFAOYSA-N
Associated Targets(non-human)
dengue virus type 2 2400 Activities
Vero 26788 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 256.13 | Molecular Weight (Monoisotopic): 255.0218 | AlogP: 4.37 | #Rotatable Bonds: 1 |
| Polar Surface Area: 33.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 6.96 | CX Basic pKa: 3.67 | CX LogP: 4.41 | CX LogD: 3.84 |
| Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.82 | Np Likeness Score: -0.41 |
References
| 1. Kaur R, Kumar K.. (2021) Synthetic and medicinal perspective of quinolines as antiviral agents., 215 [PMID:33609889] [10.1016/j.ejmech.2021.113220] |
Source
Source(1):